Are you a person living with #HIV based in Belgium, Denmark, France or Spain?

The European AIDS Treatment Group (EATG), HIV community partner within the #HIVACAR initiative, invites you to fill in ๐™– ๐™จ๐™ช๐™ง๐™ซ๐™š๐™ฎ to help better understand ๐™ฎ๐™ค๐™ช๐™ง ๐™ ๐™ฃ๐™ค๐™ฌ๐™ก๐™š๐™™๐™œ๐™š ๐™–๐™—๐™ค๐™ช๐™ฉ ๐™ƒ๐™„๐™‘ ๐™ง๐™š๐™ข๐™ž๐™จ๐™จ๐™ž๐™ค๐™ฃ (โ€˜functional cureโ€™) and ๐™ฎ๐™ค๐™ช๐™ง ๐™š๐™ญ๐™ฅ๐™š๐™˜๐™ฉ๐™–๐™ฉ๐™ž๐™ค๐™ฃ๐™จ from the research for an intervention that could enable the control of HIV infection without taking medicines every day.

The survey takes about 1๏ธ0๏ธ minutes to fill in. It is available in English, Dutch, Danish, French and Spanish

Danish: https://www.1ka.si/a/186891

Dutch: https://www.1ka.si/a/186843

English: https://www.1ka.si/a/179609

French: https://www.1ka.si/a/182281

Spanish: https://www.1ka.si/a/182262

The survey is strictly anonymous and the data will be treated with confidentiality. The results will be reported in a way that they cannot be traced back to any individual.

This survey is conducted within the framework of the HIVACAR project, funded by the European Commissionโ€™s H2020 programme.

 

The HIVACAR project also seeks to investigate new therapeutic alternatives to โ€œcART for lifeโ€ (combination Antiretroviral Therapy). ๐˜ผ ๐™˜๐™ก๐™ž๐™ฃ๐™ž๐™˜๐™–๐™ก ๐™ฉ๐™ง๐™ž๐™–๐™ก investigating a patient-tailored, safe, affordable and scalable innovative intervention that potentially could help controlling HIV infection even without antiretroviral treatment will be conducted in three European countries. The recruiting clinical sites are:

Hospital Clรญnic de Barcelona (Spain),

Hospital Germans Trias i Pujol Badalona (Spain),

Assistance Publique Hรดpitaux de Paris (France) and

Vrije Universiteit Brussel (Belgium).

You can access more information regarding community participation to HIVACAR here:ย ย http://www.hivacar.org/community/

If you have further questions about the psychosocial survey or would like to receive more information about the clinical trial, please contact us at the EATG at ๐™ฅ๐™ง๐™ค๐™Ÿ๐™š๐™˜๐™ฉ๐™จ@๐™š๐™–๐™ฉ๐™œ.๐™ค๐™ง๐™œ.

Thank you in advance for your participation and support.